XAGE
Longevity Health Holdings, Inc.
0.00 (0.00%)0.17USD0成交股數421K市值–本益比(近四季)0.3股價營收比-21.4%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 396K-21% | 392K-23% | 473K+2205% | 426K+3357% | 504K | 510K | 21K | 12K | 0 | – | 0 | 0 |
| 營業成本 | 160K | 155K | 205K | 171K | 201K | 241K | 5K | 292.00 | 0 | – | 0 | 0 |
| 毛利 | 236K-22% | 237K-12% | 268K+1608% | 254K+2016% | 303K | 270K | 16K | 12K | 0 | – | 0 | 0 |
| 毛利率 | 59.5% | 60.5% | 56.6% | 59.8% | 60.1% | 52.9% | 76.4% | 97.6% | – | – | – | – |
| 研發費用 | 73K | 55K | 135K | 228K | 229K | 197K | 332K | 104K | 429K | −658K | 1.6M | 824K |
| 銷售管理費用 | 682K | – | – | – | 1.6M | – | – | – | – | – | – | – |
| 營業利益 | −724K-61% | −1.3M-12% | −2.3M+60% | −1.5M+23% | −1.9M+35% | −1.5M+352% | −1.4M-50% | −1.2M-20% | −1.4M | −333K | −2.8M | −1.5M |
| 營業利益率 | -182.9% | -339.1% | -480.2% | -345.4% | -369.1% | -295.2% | -6,919.4% | -9,671.2% | – | – | – | – |
| 稅後淨利 | −1.9M-0% | −1.4M-5% | −2.1M-28% | −1.4M-57% | −1.9M-42% | −1.5M-148% | −2.9M-75% | −3.3M-38% | −3.3M | 3.2M | −11.5M | −5.3M |
| 淨利率 | -475.6% | -365.5% | -440.4% | -335.7% | -374.6% | -295.1% | -14,028.4% | -26,822.5% | – | – | – | – |
| 稀釋 EPS | – | -0.75-51% | -0.92-78% | -0.83-83% | -1.56-64% | -1.52-125% | -4.13+566% | -4.78-4% | -4.28 | 6.07 | -0.62 | -5.00 |
| 稀釋股數 | – | 1.9M | 1.4M | 1.7M | 1.2M | 991K | 697K | 691K | 764K | 11.0M | 18.6M | 1.1M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 35K | 313K | 707K | 1.1M | 1.6M | 770K | 1.1M | 2.2M | 892K | 2.9M | 8.0M | 16K |
| 應收帳款 | 20K | 49K | 37K | 47K | 54K | 95K | – | – | – | 0 | 14.4M | – |
| 存貨 | 607K | 735K | 963K | 1.0M | 1.2M | 1.4M | 98K | 114K | – | 0 | 9.8M | – |
| 總資產 | 1.1M | 1.6M | 2.4M | 3.3M | 3.7M | 3.3M | 2.4M | 5.0M | 6.2M | 63.9M | 82.2M | 160M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | 9.4M | – |
| 總負債 | 9.8M | 8.5M | 8.2M | 7.3M | 7.5M | 7.1M | 6.5M | 6.4M | 7.6M | 39.2M | 61.3M | 4.1M |
| 股東權益 | −8.7M | −6.9M | −5.9M | −4.0M | −3.7M | −3.8M | −4.1M | −1.4M | −1.4M | 24.7M | 20.9M | −45.1M |
| 負債比 | 924.4% | 519.8% | 347.9% | 220.6% | 200.5% | 214.0% | 266.5% | 127.3% | 122.5% | 61.3% | 74.6% | 2.6% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | −1.4M | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −485K-36% | – | – | – | −753K | – | – | −1.1M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | 13K | 15K | 16K | 16K | 22K | 24K | 18K | 24K | 24K | 24K | 23K | 26K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 1.9M | +3701.4% | −6.9M | -361.0% | -4.83 | −3.3M |
| FY2024 | 50K | – | −10.4M | -20,605.5% | -14.56 | – |
| FY2023 | 0 | – | −15.4M | –% | -1.46 | −8.4M |
| FY2022 | – | – | −9.1M | –% | -5.47 | −3.4M |
| FY2021 | – | – | −329K | –% | – | – |